TAMIFEN

This brand name is authorized in Cyprus, Hong Kong, Tunisia

Active ingredients

The drug TAMIFEN contains one active pharmaceutical ingredient (API):

1 Tamoxifen UNII 094ZI81Y45 - TAMOXIFEN

Tamoxifen is a non-steroidal, triphenylethylene-based drug which displays a complex spectrum of oestrogen antagonist and oestrogen agonist-like pharmacological effects in different tissues. Read about Tamoxifen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TAMIFEN Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02BA01	Tamoxifen	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BA Anti-estrogens
Discover more medicines within L02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 40706
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6973091, 6973092